BC
IRON icon

Boxer Capital’s Disc Medicine IRON Stock Holding History

Boxer Capital’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-130,000
Closed -$5.77M – 76
2023
Q2 		$5.77M Hold
130,000
– – 0.27% 54
2023
Q1 		$2.75M Hold
130,000
– – 0.14% 61
2022
Q4 		$176K Buy
130,000
+86,667
+200% +$4.32M 0.01% 68
2022
Q3 		$2.13M Hold
43,333
– – 0.12% 64
2022
Q2 		$2.2M Hold
43,333
– – 0.14% 66
2022
Q1 		$1.81M Hold
43,333
– – 0.09% 67
2021
Q4 		$3.78M Hold
43,333
– – 0.15% 63
2021
Q3 		$5.25M Hold
43,333
– – 0.18% 68
2021
Q2 		$8.41M Hold
43,333
– – 0.3% 69
2021
Q1 		$17.6M Buy
+43,333
New +$19.3M 0.6% 49

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Boxer Capital's IRON Position: Q3 2023 in Review

Boxer Capital sold out of Disc Medicine (IRON) in Q3 2023, closing a stake of 130,000 shares — an estimated $5.77M sold.

Boxer Capital first reported a position in IRON in Q1 2021 and held it in 10 quarters. The position peaked at $17.6M in Q1 2021. 91 funds tracked by Wall St. Rank hold IRON as of Q3 2023.

  • Boxer Capital reported no remaining Disc Medicine position as of Q3 2023 after selling out during the quarter.
  • Boxer Capital sold 130,000 Disc Medicine shares in Q3 2023, an estimated $5.77M.
  • Boxer Capital first reported a position in Disc Medicine in Q1 2021 and held it in 10 quarters.
  • Boxer Capital's Disc Medicine position peaked at $17.6M in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2023.

Based on Boxer Capital's 13F filing for Q3 2023, filed 14 Nov 2023.